Solved

The Percutaneous Introduction of Idarucizumab Dabigatran Reversal Agent into a Peripheral

Question 17

Multiple Choice

The percutaneous introduction of idarucizumab dabigatran reversal agent into a peripheral vein, new technology group 1 is reported with code _____.


A) XW01331
B) XW04331
C) XW03321
D) XW03331

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions